tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
SAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
PremiumRatingsSAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
2M ago
SAB Biotherapeutics Secures $175M in Private Placement
Premium
Company Announcements
SAB Biotherapeutics Secures $175M in Private Placement
2M ago
SAB Biotherapeutics announces oversubscribed $175M private placement
Premium
The Fly
SAB Biotherapeutics announces oversubscribed $175M private placement
2M ago
SAB Biotherapeutics price target lowered to $20 from $25 at Chardan
PremiumThe FlySAB Biotherapeutics price target lowered to $20 from $25 at Chardan
5M ago
Promising Outlook for SAB Biotherapeutics’ SAB-142: Positive Phase 1 Results and Future Growth Potential Justify Buy Rating
Premium
Ratings
Promising Outlook for SAB Biotherapeutics’ SAB-142: Positive Phase 1 Results and Future Growth Potential Justify Buy Rating
5M ago
SAB Biotherapeutics held cash and equivalents of $20.8 million at end of 2024
Premium
The Fly
SAB Biotherapeutics held cash and equivalents of $20.8 million at end of 2024
5M ago
SAB Biotherapeutics initiated with a Buy at Craig-Hallum
PremiumThe FlySAB Biotherapeutics initiated with a Buy at Craig-Hallum
11M ago
SAB Biotherapeutics Advances in Type 1 Diabetes Immunotherapy Trial
Premium
Company Announcements
SAB Biotherapeutics Advances in Type 1 Diabetes Immunotherapy Trial
12M ago
SAB Biotherapeutics provides SAB-142 clinical trial progress update
Premium
The Fly
SAB Biotherapeutics provides SAB-142 clinical trial progress update
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100